THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS
The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng ; por |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | SÁNCHEZ-QUESADA, JORGE OLGA MARTÍNEZ MONTERO BEATRIZ RODRÍGUEZ SALGUERO JAVIER LÓPEZ OGALLA SUSANA HERRERO SANTOS MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO MIGUEL MEDINA PADILLA JAVIER DE CRISTOBAL BLANCO JUAN MANUEL DOMÍNGUEZ CORREA ANA FUERTES HUERTA FRANCISCO PALOMO NICOLAU |
description | The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_PT2838888TT</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>PT2838888TT</sourcerecordid><originalsourceid>FETCH-epo_espacenet_PT2838888TT3</originalsourceid><addsrcrecordid>eNrjZNAM8fB0dPF0jPL38XTx9HN18fT3cw1WcAxWcA_21jVW8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEBIUYWxhZAEBJiTIQSAPd1JKQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><source>esp@cenet</source><creator>SÁNCHEZ-QUESADA, JORGE ; OLGA MARTÍNEZ MONTERO ; BEATRIZ RODRÍGUEZ SALGUERO ; JAVIER LÓPEZ OGALLA ; SUSANA HERRERO SANTOS ; MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO ; MIGUEL MEDINA PADILLA ; JAVIER DE CRISTOBAL BLANCO ; JUAN MANUEL DOMÍNGUEZ CORREA ; ANA FUERTES HUERTA ; FRANCISCO PALOMO NICOLAU</creator><creatorcontrib>SÁNCHEZ-QUESADA, JORGE ; OLGA MARTÍNEZ MONTERO ; BEATRIZ RODRÍGUEZ SALGUERO ; JAVIER LÓPEZ OGALLA ; SUSANA HERRERO SANTOS ; MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO ; MIGUEL MEDINA PADILLA ; JAVIER DE CRISTOBAL BLANCO ; JUAN MANUEL DOMÍNGUEZ CORREA ; ANA FUERTES HUERTA ; FRANCISCO PALOMO NICOLAU</creatorcontrib><description>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</description><language>eng ; por</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2017</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170718&DB=EPODOC&CC=PT&NR=2838888T$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76294</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20170718&DB=EPODOC&CC=PT&NR=2838888T$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SÁNCHEZ-QUESADA, JORGE</creatorcontrib><creatorcontrib>OLGA MARTÍNEZ MONTERO</creatorcontrib><creatorcontrib>BEATRIZ RODRÍGUEZ SALGUERO</creatorcontrib><creatorcontrib>JAVIER LÓPEZ OGALLA</creatorcontrib><creatorcontrib>SUSANA HERRERO SANTOS</creatorcontrib><creatorcontrib>MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO</creatorcontrib><creatorcontrib>MIGUEL MEDINA PADILLA</creatorcontrib><creatorcontrib>JAVIER DE CRISTOBAL BLANCO</creatorcontrib><creatorcontrib>JUAN MANUEL DOMÍNGUEZ CORREA</creatorcontrib><creatorcontrib>ANA FUERTES HUERTA</creatorcontrib><creatorcontrib>FRANCISCO PALOMO NICOLAU</creatorcontrib><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><description>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2017</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNAM8fB0dPF0jPL38XTx9HN18fT3cw1WcAxWcA_21jVW8PTz8HTyDPEPCuZhYE1LzClO5YXS3AwKbq4hzh66qQX58anFBYnJqXmpJfEBIUYWxhZAEBJiTIQSAPd1JKQ</recordid><startdate>20170718</startdate><enddate>20170718</enddate><creator>SÁNCHEZ-QUESADA, JORGE</creator><creator>OLGA MARTÍNEZ MONTERO</creator><creator>BEATRIZ RODRÍGUEZ SALGUERO</creator><creator>JAVIER LÓPEZ OGALLA</creator><creator>SUSANA HERRERO SANTOS</creator><creator>MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO</creator><creator>MIGUEL MEDINA PADILLA</creator><creator>JAVIER DE CRISTOBAL BLANCO</creator><creator>JUAN MANUEL DOMÍNGUEZ CORREA</creator><creator>ANA FUERTES HUERTA</creator><creator>FRANCISCO PALOMO NICOLAU</creator><scope>EVB</scope></search><sort><creationdate>20170718</creationdate><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><author>SÁNCHEZ-QUESADA, JORGE ; OLGA MARTÍNEZ MONTERO ; BEATRIZ RODRÍGUEZ SALGUERO ; JAVIER LÓPEZ OGALLA ; SUSANA HERRERO SANTOS ; MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO ; MIGUEL MEDINA PADILLA ; JAVIER DE CRISTOBAL BLANCO ; JUAN MANUEL DOMÍNGUEZ CORREA ; ANA FUERTES HUERTA ; FRANCISCO PALOMO NICOLAU</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_PT2838888TT3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; por</language><creationdate>2017</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>SÁNCHEZ-QUESADA, JORGE</creatorcontrib><creatorcontrib>OLGA MARTÍNEZ MONTERO</creatorcontrib><creatorcontrib>BEATRIZ RODRÍGUEZ SALGUERO</creatorcontrib><creatorcontrib>JAVIER LÓPEZ OGALLA</creatorcontrib><creatorcontrib>SUSANA HERRERO SANTOS</creatorcontrib><creatorcontrib>MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO</creatorcontrib><creatorcontrib>MIGUEL MEDINA PADILLA</creatorcontrib><creatorcontrib>JAVIER DE CRISTOBAL BLANCO</creatorcontrib><creatorcontrib>JUAN MANUEL DOMÍNGUEZ CORREA</creatorcontrib><creatorcontrib>ANA FUERTES HUERTA</creatorcontrib><creatorcontrib>FRANCISCO PALOMO NICOLAU</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SÁNCHEZ-QUESADA, JORGE</au><au>OLGA MARTÍNEZ MONTERO</au><au>BEATRIZ RODRÍGUEZ SALGUERO</au><au>JAVIER LÓPEZ OGALLA</au><au>SUSANA HERRERO SANTOS</au><au>MARÍA ÁNGELES PÉREZ DE LA CRUZ MORENO</au><au>MIGUEL MEDINA PADILLA</au><au>JAVIER DE CRISTOBAL BLANCO</au><au>JUAN MANUEL DOMÍNGUEZ CORREA</au><au>ANA FUERTES HUERTA</au><au>FRANCISCO PALOMO NICOLAU</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS</title><date>2017-07-18</date><risdate>2017</risdate><abstract>The present invention relates to new thiadiazolidinediones of formula (I), or any pharmaceutically acceptable salt, solvate or prodrug thereof, and its use in the treatment of a disease in which glycogen synthase kinase 3 (GSK-3) is involved, particularly neurodegenerative diseases, inflammatory and autoimmune diseases and cardiovascular disorders. Additionally, there is provided a process for preparing such compounds, as well as pharmaceutical compositions comprising them.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng ; por |
recordid | cdi_epo_espacenet_PT2838888TT |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | THIADIAZOLIDINEDIONES AS GSK-3 INHIBITORS |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-23T01%3A51%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=S%C3%81NCHEZ-QUESADA,%20JORGE&rft.date=2017-07-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EPT2838888TT%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |